Cancer-related cognitive dysfunction is an important clinical prob em that can interfere with the daily functioning, work productivi ty, childcare, and other responsibilities of women with a history of breast cancer. Risks of cancer-related cognitive impairment include cancer and cancer treatment, as well as patient-related vulnerabil ities. There is no established standard of neuroprotective care or treatment for breast cancer-related cognitive impairment.
Keywords: cancer-related cognitive impairment, breast cancer, women
Vuksanović,
G , Marić,
J , Kalajdžić,
O , Zečević,
I , Matovic,
S & Ristić,
S.
(2022) 'Post-chemotherapy cognitive dysfunction in women with breast cancer',
Biomedicinska istraživanja.
13(1)
:95-104.
doi: 10.5937/BII2201095V
Vuksanović,
G , Marić,
J , Kalajdžić,
O , Zečević,
I , Matovic,
S & Ristić,
S.
Post-chemotherapy cognitive dysfunction in women with breast cancer. Biomedicinska istraživanja. 2022 6;
13(1)
:95-104.
doi: 10.5937/BII2201095V
Vuksanović,
G Marić,
J Kalajdžić,
O Zečević,
I Matovic,
S
& Ristić,
S.
(2022, 6 30). Post-chemotherapy cognitive dysfunction in women with breast cancer.
Biomedicinska istraživanja
13(1)
:95-104.
doi: 10.5937/BII2201095V
